1st Quarter - Termination

BROWN RUDNICK LLP for APOTEX CORPORATION

Firm
Client
Income
$50,000
Expenses
—
Terminated
Feb 1, 2019

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Public Law 115-52, Section 808, relating to the Competitive Generic Therapy designation; President's FY19 budget proposal relating to generic drug 180-Day exclusivity

LobbyistCovered position, as disclosed
HENRY W MENN CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commission (93-95)

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.